deferiprone has been researched along with Porphyria Cutanea Tarda in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
Porphyria Cutanea Tarda: An autosomal dominant or acquired porphyria due to a deficiency of UROPORPHYRINOGEN DECARBOXYLASE in the LIVER. It is characterized by photosensitivity and cutaneous lesions with little or no neurologic symptoms. Type I is the acquired form and is strongly associated with liver diseases and hepatic toxicities caused by alcohol or estrogenic steroids. Type II is the familial form.
Excerpt | Relevance | Reference |
---|---|---|
"Porphyria cutanea tarda is a liver disease characterized by elevated hepatic iron and excessive production of uroporphyrin (URO)." | 1.34 | Effect of an oral iron chelator or iron-deficient diets on uroporphyria in a murine model of porphyria cutanea tarda. ( Balestra, D; Gorman, N; Jacobs, JM; Jacobs, NJ; Sinclair, JF; Sinclair, PR; Szakacs, JG; Trask, HS; Zaharia, A, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gorman, N | 1 |
Zaharia, A | 1 |
Trask, HS | 1 |
Szakacs, JG | 1 |
Jacobs, NJ | 1 |
Jacobs, JM | 1 |
Balestra, D | 1 |
Sinclair, JF | 1 |
Sinclair, PR | 1 |
1 other study available for deferiprone and Porphyria Cutanea Tarda
Article | Year |
---|---|
Effect of an oral iron chelator or iron-deficient diets on uroporphyria in a murine model of porphyria cutanea tarda.
Topics: Animals; Deferiprone; Disease Models, Animal; Iron Chelating Agents; Iron Deficiencies; Liver; Male; | 2007 |